Stockreport

Clinical trial results drove insider trading: SEC [Investment Executive - News]

C4 Therapeutics, Inc.  (CCCC) 
NASDAQ:AMEX Investor Relations: ir.chinacache.com
PDF A biostatistician working for a U.S. pharmaceutical company used information about positive results in a cancer drug trial to engage in insider trading, U.S. authoritie [Read more]